Mitotic centromere-associated kinesin (MCAK): A potential cancer drug target

Oncotarget

Volumn 2, Issue 12, 2011, Pages 935-947

  Sanhaji, Mourad ^a   Friel, Claire T ^b   Wordeman, Linda ^c   Louwen, Frank ^a   Yuan, Juping ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chromosome instability; Drug resistance and invasiveness; MCAK; Mitotic kinases

Indexed keywords

AURORA KINASE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; KIF2C PROTEIN, HUMAN; KINESIN; ONCOPROTEIN; POLO LIKE KINASE 1; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; TUBULIN;

CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; GENETICS; HUMAN; METABOLISM; MICROTUBULE; MITOSIS; MITOSIS SPINDLE; NEOPLASM; PATHOLOGY; REVIEW;

CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; HUMANS; KINESIN; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUBULIN;

EID: 84863008444     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.416     Document Type: Review

References (118)

1. Paweletz N: Walther Flemming: pioneer of mitosis research. Nat Rev Mol Cell Biol 2001, 2: 72-75.
2. Schvartzman JM, Sotillo R, Benezra R: Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 2010, 10: 102-115.
3. Thompson SL, Bakhoum SF, Compton DA: Mechanisms of chromosomal instability. Curr Biol 2010, 20: R285-R295.
4. Thompson SL, Compton DA: Chromosomes and cancer cells. Chromosome Res 2011, 19: 433-444.
5. Gadde S, Heald R: Mechanisms and molecules of the mitotic spindle. Curr Biol 2004, 14: R797-R805.
6. Wordeman L: Microtubule-depolymerizing kinesins. Curr Opin Cell Biol 2005, 17: 82-88.
7. Howard J, Hyman AA: Microtubule polymerases and depolymerases. Curr Opin Cell Biol 2007, 19: 31-35.
8. Manning AL, Ganem NJ, Bakhoum SF, Wagenbach M, Wordeman L, Compton DA: The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 2007, 18: 2970-2979.
9. Bakhoum SF, Genovese G, Compton DA: Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol 2009, 19: 1937-1942.
10. Bakhoum SF, Thompson SL, Manning AL, Compton DA: Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol 2009, 11: 27-35.
11. Ems-McClung SC, Walczak CE: Kinesin-13s in mitosis: Key players in the spatial and temporal organization of spindle microtubules. Semin Cell Dev Biol 2010, 21: 276-282.
12. Tanenbaum ME, Medema RH, Akhmanova A: Regulation of localization and activity of the microtubule depolymerase MCAK. Bioarchitecture 2011, 1: 80-87.
13. Desai A, Verma S, Mitchison TJ, Walczak CE: Kin I kinesins are microtubule-destabilizing enzymes. Cell 1999, 96: 69-78.
14. Ogawa T, Nitta R, Okada Y, Hirokawa N: A common mechanism for microtubule destabilizers-M type kinesins stabilize curling of the protofilament using the classspecific neck and loops. Cell 2004, 116: 591-602.
15. Lawrence CJ, Dawe RK, Christie KR, Cleveland DW, Dawson SC, Endow SA et al.: A standardized kinesin nomenclature. J Cell Biol 2004, 167: 19-22.
16. Rogers GC, Rogers SL, Schwimmer TA, Ems-McClung SC, Walczak CE, Vale RD et al.: Two mitotic kinesins cooperate to drive sister chromatid separation during anaphase. Nature 2004, 427: 364-370.
17. Noda Y, Sato-Yoshitake R, Kondo S, Nangaku M, Hirokawa N: KIF2 is a new microtubule-based anterograde motor that transports membranous organelles distinct from those carried by kinesin heavy chain or KIF3A/B. J Cell Biol 1995, 129: 157-167.
18. Miki H, Setou M, Kaneshiro K, Hirokawa N: All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci U S A 2001, 98: 7004-7011.
19. Wordeman L, Mitchison TJ: Identification and partial characterization of mitotic centromere-associated kinesin, a kinesin-related protein that associates with centromeres during mitosis. J Cell Biol 1995, 128: 95-104.
20. Ganem NJ, Compton DA: The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK. J Cell Biol 2004, 166: 473-478.
21. Ganem NJ, Upton K, Compton DA: Efficient mitosis in human cells lacking poleward microtubule flux. Curr Biol 2005, 15: 1827-1832.
22. Moore AT, Rankin KE, von Dassow G, Peris L, Wagenbach M, Ovechkina Y et al.: MCAK associates with the tips of polymerizing microtubules. J Cell Biol 2005, 169: 391-397.
23. Lee T, Langford KJ, Askham JM, Bruning-Richardson A, Morrison EE: MCAK associates with EB1. Oncogene 2008, 27: 2494-2500.
24. Honnappa S, Gouveia SM, Weisbrich A, Damberger FF, Bhavesh NS, Jawhari H et al.: An EB1-binding motif acts as a microtubule tip localization signal. Cell 2009, 138: 366-376.
25. Kobayashi T, Tsang WY, Li J, Lane W, Dynlacht BD: Centriolar kinesin Kif24 interacts with CP110 to remodel microtubules and regulate ciliogenesis. Cell 2011, 145: 914-925.
26. Helenius J, Brouhard G, Kalaidzidis Y, Diez S, Howard J: The depolymerizing kinesin MCAK uses lattice diffusion to rapidly target microtubule ends. Nature 2006, 441: 115-119.
27. Maney T, Wagenbach M, Wordeman L: Molecular dissection of the microtubule depolymerizing activity of mitotic centromere-associated kinesin. J Biol Chem 2001, 276: 34753-34758.
28. Ovechkina Y, Wagenbach M, Wordeman L: K-loop insertion restores microtubule depolymerizing activity of a "neckless" MCAK mutant. J Cell Biol 2002, 159: 557-562.
29. Cooper JR, Wagenbach M, Asbury CL, Wordeman L: Catalysis of the microtubule on-rate is the major parameter regulating the depolymerase activity of MCAK. Nat Struct Mol Biol 2010, 17: 77-82.
30. Shipley K, Hekmat-Nejad M, Turner J, Moores C, Anderson R, Milligan R et al.: Structure of a kinesin microtubule depolymerization machine. EMBO J 2004, 23: 1422-1432.
31. Elie-Caille C, Severin F, Helenius J, Howard J, Muller DJ, Hyman AA: Straight GDP-tubulin protofilaments form in the presence of taxol. Curr Biol 2007, 17: 1765-1770.
32. Moores CA, Yu M, Guo J, Beraud C, Sakowicz R, Milligan RA: A mechanism for microtubule depolymerization by KinI kinesins. Mol Cell 2002, 9: 903-909.
33. Niederstrasser H, Salehi-Had H, Gan EC, Walczak C, Nogales E: XKCM1 acts on a single protofilament and requires the C terminus of tubulin. J Mol Biol 2002, 316: 817-828.
34. Tan D, Asenjo AB, Mennella V, Sharp DJ, Sosa H: Kinesin-13s form rings around microtubules. J Cell Biol 2006, 175: 25-31.
35. Friel CT, Howard J: The kinesin-13 MCAK has an unconventional ATPase cycle adapted for microtubule depolymerization. EMBO J 2011, 30: 3928-3939.
36. Oguchi Y, Uchimura S, Ohki T, Mikhailenko SV, Ishiwata S: The bidirectional depolymerizer MCAK generates force by disassembling both microtubule ends. Nat Cell Biol 2011, 13: 846-852.
37. Maney T, Hunter AW, Wagenbach M, Wordeman L: Mitotic centromere-associated kinesin is important for anaphase chromosome segregation. J Cell Biol 1998, 142: 787-801.
38. Walczak CE, Mitchison TJ, Desai A: XKCM1: a Xenopus kinesin-related protein that regulates microtubule dynamics during mitotic spindle assembly. Cell 1996, 84: 37-47.
39. Walczak CE, Gan EC, Desai A, Mitchison TJ, Kline-Smith SL: The microtubule-destabilizing kinesin XKCM1 is required for chromosome positioning during spindle assembly. Curr Biol 2002, 12: 1885-1889.
40. Holmfeldt P, Stenmark S, Gullberg M: Differential functional interplay of TOGp/XMAP215 and the KinI kinesin MCAK during interphase and mitosis. EMBO J 2004, 23: 627-637.
41. Cassimeris L, Morabito J: TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. Mol Biol Cell 2004, 15: 1580-1590.
42. Wordeman L, Wagenbach M, von Dassow G: MCAK facilitates chromosome movement by promoting kinetochore microtubule turnover. J Cell Biol 2007, 179: 869-879.
43. Kline-Smith SL, Khodjakov A, Hergert P, Walczak CE: Depletion of centromeric MCAK leads to chromosome congression and segregation defects due to improper kinetochore attachments. Mol Biol Cell 2004, 15: 1146-1159.
44. Pihan G, Doxsey SJ: Mutations and aneuploidy: coconspirators in cancer? Cancer Cell 2003, 4: 89-94
45. Ohi R, Coughlin ML, Lane WS, Mitchison TJ: An inner centromere protein that stimulates the microtubule depolymerizing activity of a KinI kinesin. Dev Cell 2003, 5: 309-321.
46. Huang H, Feng J, Famulski J, Rattner JB, Liu ST, Kao GD et al.: Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J Cell Biol 2007, 177: 413-424.
47. Groen AC, Maresca TJ, Gatlin JC, Salmon ED, Mitchison TJ: Functional overlap of microtubule assembly factors in chromatin-promoted spindle assembly. Mol Biol Cell 2009, 20: 2766-2773.
48. Jiang K, Wang J, Liu J, Ward T, Wordeman L, Davidson A et al.: TIP150 interacts with and targets MCAK at the microtubule plus ends. EMBO Rep 2009, 10: 857-865.
49. Beardmore VA, Ahonen LJ, Gorbsky GJ, Kallio MJ: Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J Cell Sci 2004, 117: 4033-4042.
50. Ruchaud S, Carmena M, Earnshaw WC: Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007, 8: 798-812.
51. Jeyaprakash AA, Klein UR, Lindner D, Ebert J, Nigg EA, Conti E: Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131: 271-285.
52. Vigneron S, Prieto S, Bernis C, Labbe JC, Castro A, Lorca T: Kinetochore localization of spindle checkpoint proteins: who controls whom? Mol Biol Cell 2004, 15: 4584-4596
53. Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T et al.: Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 2003, 161: 267-280.
54. Lens SM, Wolthuis RM, Klompmaker R, Kauw J, Agami R, Brummelkamp T et al.: Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J 2003, 22: 2934-2947.
55. Emanuele MJ, Lan W, Jwa M, Miller SA, Chan CS, Stukenberg PT: Aurora B kinase and protein phosphatase 1 have opposing roles in modulating kinetochore assembly. J Cell Biol 2008, 181: 241-254.
56. Pouwels J, Kukkonen AM, Lan W, Daum JR, Gorbsky GJ, Stukenberg T et al.: Shugoshin 1 plays a central role in kinetochore assembly and is required for kinetochore targeting of Plk1. Cell Cycle 2007, 6: 1579-1585.
57. Goto H, Kiyono T, Tomono Y, Kawajiri A, Urano T, Furukawa K et al.: Complex formation of Plk1 and INCENP required for metaphase-anaphase transition. Nat Cell Biol 2006, 8: 180-187.
58. Kawashima SA, Tsukahara T, Langegger M, Hauf S, Kitajima TS, Watanabe Y: Shugoshin enables tensiongenerating attachment of kinetochores by loading Aurora to centromeres. Genes Dev 2007, 21: 420-435.
59. Kelly AE, Funabiki H: Correcting aberrant kinetochore microtubule attachments: an Aurora B-centric view. Curr Opin Cell Biol 2009, 21: 51-58.
60. Lan W, Zhang X, Kline-Smith SL, Rosasco SE, Barrett-Wilt GA, Shabanowitz J et al.: Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol 2004, 14: 273-286.
61. Andrews PD, Ovechkina Y, Morrice N, Wagenbach M, Duncan K, Wordeman L et al.: Aurora B regulates MCAK at the mitotic centromere. Dev Cell 2004, 6: 253-268.
62. Ohi R, Sapra T, Howard J, Mitchison TJ: Differentiation of cytoplasmic and meiotic spindle assembly MCAK functions by Aurora B-dependent phosphorylation. Mol Biol Cell 2004, 15: 2895-2906.
63. Zhang X, Lan W, Ems-McClung SC, Stukenberg PT, Walczak CE: Aurora B phosphorylates multiple sites on mitotic centromere-associated kinesin to spatially and temporally regulate its function. Mol Biol Cell 2007, 18: 3264-3276.
64. Cimini D, Wan X, Hirel CB, Salmon ED: Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors. Curr Biol 2006, 16: 1711-1718.
65. Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R et al.: The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol 2003, 161: 281-294.
66. Knowlton AL, Lan W, Stukenberg PT: Aurora B is enriched at merotelic attachment sites, where it regulates MCAK. Curr Biol 2006, 16: 1705-1710.
67. Marumoto T, Zhang D, Saya H: Aurora-A - a guardian of poles. Nat Rev Cancer 2005, 5: 42-50.
68. Barr AR, Gergely F: Aurora-A: the maker and breaker of spindle poles. J Cell Sci 2007, 120: 2987-2996.
69. Lens SM, Voest EE, Medema RH: Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 2010, 10: 825-841.
70. Kufer TA, Sillje HH, Korner R, Gruss OJ, Meraldi P, Nigg EA: Human TPX2 is required for targeting Aurora-A kinase to the spindle. J Cell Biol 2002, 158: 617-623.
71. Hutterer A, Berdnik D, Wirtz-Peitz F, Zigman M, Schleiffer A, Knoblich JA: Mitotic activation of the kinase Aurora-A requires its binding partner Bora. Dev Cell 2006, 11: 147-157.
72. Hoar K, Chakravarty A, Rabino C, Wysong D, Bowman D, Roy N et al.: MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy. Mol Cell Biol 2007, 27: 4513-4525.
73. Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W et al.: Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc Natl Acad Sci U S A 2007, 104: 4106-4111.
74. De Luca M, Brunetto L, Asteriti IA, Giubettini M, Lavia P, Guarguaglini G: Aurora-A and ch-TOG act in a common pathway in control of spindle pole integrity. Oncogene 2008, 27: 6539-6549.
75. Zhang X, Ems-McClung SC, Walczak CE: Aurora A phosphorylates MCAK to control ran-dependent spindle bipolarity. Mol Biol Cell 2008, 19: 2752-2765.
76. Sanhaji M, Friel CT, Kreis NN, Kramer A, Martin C, Howard J et al.: Functional and spatial regulation of mitotic centromere-associated kinesin by cyclin-dependent kinase Mol Cell Biol 2010, 30: 2594-2607.
77. Strebhardt K: Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov 2010, 9: 643-660.
78. Sunkel CE, Glover DM: polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 1988, 89 (Pt 1): 25-38.
79. Petronczki M, Lenart P, Peters JM: Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1. Dev Cell 2008, 14: 646-659.
80. De Cárcer G, Manning G, Malumbres M: From Plk1 to Plk5: functional evolution of polo-like kinases. Cell Cycle 2011, 10: 2255-2262.
81. Elia AE, Cantley LC, Yaffe MB: Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 2003, 299: 1228-1231.
82. Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K et al.: The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 2003, 115: 83-95.
83. Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK et al.: Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell 2006, 24: 409-422.
84. Neef R, Preisinger C, Sutcliffe J, Kopajtich R, Nigg EA, Mayer TU et al.: Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J Cell Biol 2003, 162: 863-875.
85. Reindl W, Yuan J, Kramer A, Strebhardt K, Berg T: Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions. Chem Biol 2008, 15: 459-466.
86. Yuan J, Sanhaji M, Kramer A, Reindl W, Hofmann M, Kreis NN et al.: Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol 2011, 179: 2091-2099.
87. Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, Strebhardt K: Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol 1997, 150: 1165-1172.
88. Eckerdt F, Yuan J, Strebhardt K: Polo-like kinases and oncogenesis. Oncogene 2005, 24: 267-276.
89. Oliveras-Ferraros C, Vazquez-Martin A, Menendez JA: Genome-wide inhibitory impact of the AMPK activator metformin on [kinesins, tubulins, histones, auroras and polo-like kinases] M-phase cell cycle genes in human breast cancer cells. Cell Cycle 2009, 8: 1633-1636.
90. Rosasco-Nitcher SE, Lan W, Khorasanizadeh S, Stukenberg PT: Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation. Science 2008, 319: 469-472.
91. Zhang L, Shao H, Huang Y, Yan F, Chu Y, Hou H et al.: PLK1 phosphorylates MCAK and promotes its depolymerase activity. J Biol Chem 2010.
92. Santamaria A, Wang B, Elowe S, Malik R, Zhang F, Bauer M et al.: The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics 2011, 10: M110.
93. Tanenbaum ME, Macurek L, van der Vaart B, Galli M, Akhmanova A, Medema RH: A complex of Kif18b and MCAK promotes microtubule depolymerization and is negatively regulated by Aurora kinases. Curr Biol 2011, 21: 1356-1365.
94. Gardner MK, Zanic M, Gell C, Bormuth V, Howard J: Depolymerizing Kinesins Kip3 and MCAK Shape Cellular Microtubule Architecture by Differential Control of Catastrophe. Cell 2011, 147: 1092-1103.
95. Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F et al.: Genome-wide gene-expression profiles of breastcancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol 2004, 25: 797-819.
96. Eisen A, Weber BL: Recent advances in breast cancer biology. Curr Opin Oncol 1998, 10: 486-491.
97. Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, Park JH et al.: Involvement of kinesin family member 2C/ mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 2008, 99: 62-70.
98. Nakamura Y, Tanaka F, Haraguchi N, Mimori K, Matsumoto T, Inoue H et al.: Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 2007, 97: 543-549.
99. Ishikawa K, Kamohara Y, Tanaka F, Haraguchi N, Mimori K, Inoue H et al.: Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. Br J Cancer 2008, 98: 1824-1829.
100. Gnjatic S, Cao Y, Reichelt U, Yekebas EF, Nolker C, Marx AH et al.: NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. Int J Cancer 2010, 127: 381-393.
101. Bie L, Zhao G, Wang YP, Zhang B: Kinesin family member 2C (KIF2C/MCAK) is a novel marker for prognosis in human gliomas. Clin Neurol Neurosurg 2011.
102. Kalluri R, Weinberg RA: The basics of epithelialmesenchymal transition. J Clin Invest 2009, 119: 1420-1428.
103. Nagase H, Nakamura Y: Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat 1993, 2: 425-434.
104. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87: 159-170.
105. Aoki K, Taketo MM: Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007, 120: 3327-3335.
106. Komarova Y, De Groot CO, Grigoriev I, Gouveia SM, Munteanu EL, Schober JM et al.: Mammalian end binding proteins control persistent microtubule growth. J Cell Biol 2009, 184: 691-706.
107. Kavallaris M: Microtubules and resistance to tubulinbinding agents. Nat Rev Cancer 2010, 10: 194-204.
108. Dumontet C, Jordan MA: Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 2010, 9: 790-803.
109. Ganguly A, Yang H, Cabral F: Overexpression of mitotic centromere-associated Kinesin stimulates microtubule detachment and confers resistance to paclitaxel. Mol Cancer Ther 2011, 10: 929-937.
110. Ganguly A, Yang H, Pedroza M, Bhattacharya R, Cabral F: Mitotic Centromere-associated Kinesin (MCAK) Mediates Paclitaxel Resistance. J Biol Chem 2011, 286: 36378-36384.
111. Kawamoto M, Tanaka F, Mimori K, Inoue H, Kamohara Y, Mori M: Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response. Oncol Rep 2011, 25: 469-476.
112. Rello-Varona S, Vitale I, Kepp O, Senovilla L, Jemaa M, Metivier D et al.: Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5. Cell Cycle 2009, 8: 1030-1035.
113. Hedrick DG, Stout JR, Walczak CE: Effects of antimicrotubule agents on microtubule organization in cells lacking the kinesin-13 MCAK. Cell Cycle 2008, 7: 2146-2156.
114. Rizk RS, Bohannon KP, Wetzel LA, Powers J, Shaw SL, Walczak CE: MCAK and paclitaxel have differential effects on spindle microtubule organization and dynamics. Mol Biol Cell 2009, 20: 1639-1651.
115. Rankin KE, Wordeman L: Long astral microtubules uncouple mitotic spindles from the cytokinetic furrow. J Cell Biol 2010, 190: 35-43.
116. Aoki S, Ohta K, Yamazaki T, Sugawara F, Sakaguchi K: Mammalian mitotic centromere-associated kinesin (MCAK): a new molecular target of sulfoquinovosylacylglycerols novel antitumor and immunosuppressive agents. FEBS J 2005, 272: 2132-2140.
117. McClelland SE, Burrell RA, Swanton C: Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy. Cell Cycle 2009, 8: 3262-3266.
118. Ho CC, Hau PM, Marxer M, Poon RY: The requirement of p53 for maintaining chromosomal stability during tetraploidization. Oncotarget 2010, 1: 583-595.